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Introduction: Intrauterine Growth Restriction (IUGR) refers to an impaired development
of the fetus and hence results in adverse neurodevelopmental and psychiatric
consequences later in life. Lactoferrin (Lf) is a glycoprotein present in milk that has already
shown neuroprotective effects through its anti-inflammatory and antioxidant properties
on impaired developing brains. The aim of this study was to characterize a rat model of
IUGR and assess the neuroprotective effect of a nutritional supplementation with bovine
Lf during pregnancy and lactation on this model.
Methods: A model of 50% gestational caloric restriction (CR) was used. Three groups
were designed, and pregnant rats had either ad libitum access to food (control group,
CTL) or 50% of the controls’ intake (restricted group, IUGR). The diet was isocaloric
and supplemented with bovine Lf for the caloric restricted dams (restricted-Lf, IUGR_Lf).
At postnatal day 7 and 21, advanced ex-vivo diffusion MRI techniques at 9.4T were
used to investigate brain cortical and white matter microstructure. Further, genes
and proteins involved in structure (synaptophysin, MBP), microglia (Iba-1), metabolism
(MCT2, βCaMKII) and apoptosis (Bcl-2) were analyzed in the cortex and striatum. In the
cortex, the number of parvalbumin immunoreactive interneurons and their perineuronal
nets were quantified. Behavioral tests were performed at P31.
Results: Effects of the CR were significant in the cortex and striatum with reduction of
synaptophysin (marker of synaptogenesis) at P7 andMBP (marker of myelin) at P21 in the
cortex. Indeed, MCT2 (energy metabolism), Bcl-2 (anti-apoptotic protein) and βCaMKII
(synapse activity) expressions were reduced in IUGR groups at P7. In the striatum NG2
(marker of oligodendrocyte precursor cells) and Bcl-2 at P7 as well as βCaMKII at P21
were decreased following IUGR and restored by Lf. Cortical microstructure was impaired
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following CR with partial effect of Lf. Lf prevented oxidative stress induced parvalbumin
interneurons impairments whereas striatum and external capsule showed alterations in
microstructure depicted by diffusion MRI, which were also partially reversed by Lf.
Discussion and Conclusion: The model of 50% caloric restriction induced mild
impairment partially reversed by nutritional intervention using Lf during pregnancy
and lactation.
Keywords: intrauterine growth restriction, caloric restriction, lactoferrin, neuroprotection, magnetic resonance
imaging
HIGHLIGHTS
- Moderate undernutrition induced IUGR demonstrated mild
cerebral impairment.
- Cerebral impairment is characterized by white and gray
matters damage depicted by MRI.
- Oral Lf supplementation showed partial neuroprotection
following caloric restriction during gestation.
- It represents a promising approach to reduce developmental
diseases in IUGR and preterm infants.
INTRODUCTION
The definition of intrauterine growth retardation (IUGR) given
by world health organization in 1995 was “An infant suffering
from IUGR is defined as being below the 10% percentile of
the recommended gender-specific birthweight for gestational age
reference curves.” It is one of the main causes of developmental
brain damage with possible long life neurodevelopmental
disabilities. If IUGR is an important public health concern
worldwide, the rate of IUGR in the developing countries is
about six times higher than in developed countries with at
least 30 million IUGR infants per year. Poor antenatal and
postnatal nutrition further prevents infants from attaining their
full developmental potential. IUGR adults show a higher risk of
altered cognitive and executive function and emotion control.
The often-associated morbidities of IUGR, prematurity and poor
postnatal growth represent a major risk for poor development of
affective cognition and psychiatric disorders (1–3).
Lactoferrin (Lf), an iron-binding glycoprotein is involved in
the intestinal iron uptake and regulates immune response
with anti-inflammatory as well as antioxidant property
(4, 5). In humans, higher concentration of Lf is found
in the colostrum but Lf level decreases through lactation
period (6). After oral administration, Lf is regulated through
binding sites on brain endothelial cells allowing the passage
from blood to tissues including the brain (7). Lf has been
shown to down-regulate inflammation in lipopolysaccharides
injury models (8). Importantly, Lf nutritional supplement in
preterm shows significant reduction in late-onset sepsis and
necrotizing enterocolitis (9). Our previous studies explored
the effect of Lf on various animal models of perinatal brain
injuries. Hypoxic-Ischemic post-natal day 3 (P3) pup rats
demonstrated recovery with maternal Lf supplementation
during lactation (10), characterized by a reduced cortical loss and
an altered white matter recovery. Furthermore, inflammatory
and apoptotic gene expressions were also reduced (10).
Following lipopolysaccharides injection at P3, Lf administration
during lactation reduced ventriculomegaly as well as impaired
microstructure and white matter alterations (11). Finally, in a
model of dexamethasone induced IUGR mimicking maternal
stress and fetal growth restriction, the abnormal levels of brain
metabolites as well as major neurotrophic factor (BDNF) were
restored with Lf (12). Taken together, these findings suggest
that Lf, with its anti-inflammatory and antioxidant properties,
has great potential to reduce brain injury, improve cerebral
development and prevent noxious programming due to adverse
pre and postnatal conditions.
As such, the aim of this study was to evaluate structural and
functional cerebral impairments in gestational caloric restriction
induced IUGR as well as the potential neuroprotective effect of
Lf supplementation. Effects of caloric restriction were assessed
with advanced diffusion magnetic resonance imaging techniques
[diffusion tensor imaging (DTI) as well as neurite orientation
dispersion and density imaging (NODDI)] in conjunction with
protein and gene expressions and behavioral tests.
MATERIALS AND METHODS
Animal Preparation
All experimental protocols have been previously approved by
the Animal Research Ethics of Geneva, Switzerland (#GE7115).
Nulliparous Wistar female (225–250 g) and Wistar male (250–
275 g) rats (Charles River Laboratories, France) were used
for breeding. During gestation, they had either ad libitum
access to food: Control group (CTL) or access to 50% of the
controls’ intake: Restricted group (IUGR). Bovine lactoferrin (Lf)
(Taradon laboratory, Tubize, Belgium) at an expected dose of
1g/kg/day according to daily intake of food by gestating and
lactating dams, was added to the diet as a supplementation
also during gestation and lactation for the Restricted-Lactoferrin
group (IUGR_Lf). From the day before the parturition and
during the whole lactation, all dams had ad libitum access to food,
with either Lf enriched (1 g/kg/day) or isocaloric diet. Standard
animal housing conditions according to the animal facility of
the CMU, University of Geneva, were applied with free access to
water. At birth, rat pups were culled or boarded out to another
dam of the same group in order to control litter size to 10 to
12 pups per dam until weaning day. Dam and pup weight gain
were measured daily until weaning and once a week until P42.
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The number of pups per group is mentioned by experiment
separately. The number of dams used in the study was: 6 controls,
10 IUGR and 9 IUGR_Lf.
Brain Collection for ex-vivo MRI and
Immunofluorescence
After intraperitoneal injection of pentobarbital (50 µg/kg), rat
pups were intra-cardially perfused with 0.9% NaCl and 4%
paraformaldehyde solution at postnatal day 7 (P7) and 21 (P21).
Brains were removed and immersed in 4% paraformaldehyde
overnight for post fixation.
Magnetic Resonance (MR) Experiments
All MR experiments were performed on an actively-shielded
9.4T/31 cm magnet (Varian/Magnex) equipped with 12-cm
gradient coils (400 mT/m, 120 µs). Ex-vivo MRI was performed
on P7 (CTL; n = 6, IUGR; n = 6, and IUGR_Lf; n = 6) and
P21 (CTL; n = 7, IUGR; n = 4, and IUGR_Lf; n = 4) fixed
brains with a 2.5mm diameter birdcage coil. A multi-b-value
shell protocol was acquired using a spin-echo sequence with a
field-of-view equal to 21× 16 mm2 and a matrix size of 128× 92.
Twelve slices of 0.6mm thickness were acquired with 3 averages
and TE/TR = 45/2,000ms. Ninety-six diffusion weighted images
were acquired including 15 b0 images and 81 images separated
in 3 non-collinear shells with a uniform distribution in each
shell. Distribution of number of directions and b-value were as
follow: 21 directions at a b-value of 1,750 s/mm2, 30 directions
at a b-value of 3,400 s/mm2 and 30 directions at a b-value of
5,100 s/mm2. NODDI toolbox (13) was used to fit the acquired
data. Regions of interest were delineated in cortex (Cx), external
capsule (EC), and striatum (St). DTI derived parameters [Axial
diffusivity (AD), Radial diffusivity (RD), Mean diffusivity (MD)
and Fractional anisotropy (FA)] as well as NODDI derived
parameters [intra-neurite volume faction (ficvf ), isotropic volume
fraction (fiso) and orientation dispersion index (ODI)] were
averaged in the different regions assessed as previously used in
animal models of perinatal brain injuries (11, 14).
Tissue Collection for Protein and Gene
Expression
Rat pups were euthanized by decapitation at P7 and P21.
Pups were anesthetized with pentobarbital (50 µg/kg) prior to
decapitation. Brains were quickly removed, dissected on ice and
frozen instantly in liquid nitrogen. Two structures were dissected:
cortex (Cx) and striatum (S). The samples were stored at −80◦C
until analyses.
Immunoblotting
Brain tissues from P7 (CTL; n = 6, IUGR; n = 6 and IUGR_Lf;
n = 7) and P21 (CTL; n = 10, IUGR; n = 14 and IUGR_Lf;
n= 13) rats were homogenized by sonication in RIPA buffer (Cell
Signaling, 9806S), and the protein concentration was assessed
using a Bradford assay. Proteins (25 µg) were separated by SDS-
PAGE, transferred to a nitrocellulose membrane and analyzed
by immunoblotting. All antibodies (Table 1) were diluted in
blocking buffer containing 0.1% casein (Sigma-Aldrich, C8654).
Antibodies were diluted in the concentrations suggested on the
data sheet by the manufacturer (Table 1). After incubation of
the primary antibodies, the following secondary antibodies were
applied: goat anti-mouse IgG (H+L) conjugated with DylightTM
680 (#5470, Cell Signaling Technology), goat anti-rabbit IgG
conjugated with IRDye 800 (926-32210, LI-COR) and donkey
anti-goat IgG conjugated with IRDye 680 (926-68074, LI-COR).
The Odyssey Infra-red Imaging system (LI-COR) was used to
visualize the protein bands. The densitometry was assessed by
normalizing the optical density of each sample with respect to
actin expression (mouse monoclonal anti-actin from Millipore,
MAB1501), using Image Studio Lite ver.5.2 software. The results
are expressed as a percentage of values obtained either for
the control or for the restricted rat pups (100%) using actin
as a standard.
Real-Time Quantitative PCR (RT-qPCR)
The extraction of the total mRNAwas done using the RNaseMini
Kit (Qiagen, 74104) following the manufacturer’s instructions
(Table 2). On P7 collected brains, 3 µg mRNA from the three
regions of interest at P7 (CTL; n= 6, IUGR; n= 6 and IUGR_Lf;
n = 6) and P21 (CTL; n = 6, IUGR; n = 8 and IUGR_Lf; n = 8)
were reverse transcripted to cDNA using 400 units of Moloney
murine leukemia virus reverse transcriptase (Invitrogen, 28025-
013), 20 units of recombinant RNAsin (Promega, N2515), 0.5
µg of random hexamers (ThermoFischer Scientific, #S0142),
2 mmol/L dNTP (Invitrogen, 10297018), and 40 mmol/L of
dithiothreitol (Invitrogen, 18080093). Real-time quantitative
PCR was performed with the PowerUp SYBR Green Master Mix
(Applied Biosystems, A25742) and using an StepOnePlusTMReal-
Time PCR System (Applied Biosystems). Gene expressions were
normalized using the housekeeping ribosomal gene RPS29.
The results were calculated using the Livak approach and are
expressed in arbitrary units (A.U) (12).
Quantification of Mitochondrial Oxidative
Damage and Parvalbumin Immunoreactive
Interneurons
Coronal frozen sections (40µm) were used to investigate the
anterior cingulate cortex (ACC), a region in the prefrontal
cortex known to be sensitive to stress. Triple immunolabeling
for labeling DNA oxidative damage, parvalbumin (PV), and
perineuronal nets (PNNs) was performed as followed. An
antibody against 8-oxo-2′-deoxyguanosine (8-oxo-dG), a
product of DNA oxidation, was used as DNA oxidative marker,
while the PNNs were labeled with the lectin Wisteria floribunda
Agglutinin (WFA), which binds the N-acetylgalactosamines
in chondroitin sulfate proteoglycans (15, 16). Brain sections
containing the anterior ACC were first incubated with PBS
+ Triton 0.3% +sodium azide (1 g/L) containing 2–3%
normal horse serum, then placed for 48 h in a solution with a
mouse monoclonal anti-8-oxodG (1:400; AMS Biotechnology,
Switzerland) and a rabbit polyclonal anti-parvalbumin (PV)
(1:2,500; Swant Inc., Switzerland) primary antibody together
with the biotin-conjugated WFA (1:2,000; Sigma, Switzerland).
Sections were then washed, incubated with fluorescent secondary
antibody conjugates: goat anti-mouse Alexa 488 (1:300; Life
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TABLE 1 | Primary antibodies for immunoblotting including catalog numbers, companies, and dilutions.
Abbreviations Primary antibodies Catalog number/Company Dilution
Actin Anti-actin antibody clone C4 MAB1501/Millipore 1/1,000
CD68 Rabbit polyclonal anti-CD68 250594/AbbiotecTM 1/500
DCX Rabbit polyclonal anti-DCX ab18723/Abcam 1/1,000
GFAP Mouse monoclonal anti-GFAP G6171/Sigma-Aldrich 1/1,000
Iba-1 Goat polyclonal anti-Iba1 ab5076/Abcam 1/1,000
MBP Mouse monoclonal anti-MBP ab62631/Abcam 1/1,000
NeuN Mouse monoclonal anti-NeuN MAB377/Millipore 1/1,000
NG2 Rabbit polyclonal anti-NG2 ab129051/Abcam 1/1,000
Synaptophysin Mouse monoclonal anti-synaptophysin ab8049/Abcam 1/500
βCaMKII Rabbit polyclonal anti-CAMKII beta ab34703/Abcam 1/1,000
DMT1 Rabbit polyclonal anti-DMT1 ab140977/Abcam 1/1,000
GLT1 Guinea pig polyclonal anti- GLT1 AB1783/Millipore 1/500
Leptin receptor Rabbit polyclonal anti-Leptin Receptor ab5593/Abcam 1/1,000
MCT2 Rabbit polyclonal anti-MCT2 AB3542/Millipore 1/1,000
NMDAR Rabbit polyclonal anti-NMDA R2A ab14596/Abcam 1/1,000
IGF 2 Rabbit polyclonal anti-IGF2 ab9574/Abcam 0.2 µg/mL
TrkB Rabbit polyclonal anti-TrkB ab18987/Abcam 1/1,000
Fractin Rabbit polyclonal anti-Fractin AB3150/Millipore 1/1,000
TABLE 2 | PCR primers for quantitative real-time PCR.
Primer Forward Reverse
Bax 5′-TGGAGCTGCAGAGGATGATTG-3′ 5′-GCTGCCACACGGAAGAAGAC-3′
Bcl-2 5′-TGGGATGCCTTTGTGGAACT-3′ 5′-GAGACAGCCAGGAGAAATCAAAC-3′
BDNF 5′-AAAAAGTTCCACCAGGTGAGAAGA-3′ 5′-GCAACCGAAGTATGAAATAACCATAG-3′
RPS29 5′-GCCAGGGTTCTCGCTCTTG-3′ 5′-GGCACATGTTCAGCCCGTAT-3′
Technologies, USA), goat anti-rabbit CY3 (1:300; Chemicon
International, USA) and streptavidin 405 conjugate (1:300;
Millipore Corporation, USA). Sections were visualized and
processed with a Zeiss confocal microscope equipped with
×20 and ×40 Plan-NEOFLUAR objectives. All peripherals
were controlled with LSM 710 Quasar software (Carl Zeiss AG,
Switzerland). With the triple immunolabeling of 8-oxodG, PV,
and WFA, Z-stacks of 12 images with ×20 objective (with a
1.8µm interval) were scanned (1,024 × 1,024 pixels). Images
were filtered with a Gaussian filter to remove background noise
and sharpen cell profile contour. Only the inner 9 images of Z-
stacks were used for the analyses. The stack images were merged
in a tif file with Imaris. Analyses were performed in a delineated
region of interest (ROI) comprising the ACC (mainly cg1 and
small portion of cg2) by an observer unaware of the experimental
groups. To quantify the overall 8-oxo-dG, the staining intensity
and number of labeled voxels within the ROI were measured.
For PV-IR cell count, PV cell bodies were counted and their
mean intensity of labeling (arbitrary unit) also obtained. To
analyze the number of PV+ cells surrounded by WFA labeled
PNN (WFA+ PV), we used the same “spots module” used to
count PV+ cells to assign spot markings on the profile-labeled
voxels that fall within a given size. Briefly, the channels for PV
and WFA immunolabeling were chosen, and the profile size
criterion (>8 and >5mm, respectively) was defined to quantify
stained profiles above these given sizes. The procedure was
visually monitored/verified before proceeding. Spots generated
for PV that contacted/overlapped with spots generated for
WFA (PNN) were considered as those PVI surrounded by PNN
(WFA-positive PVI).
Behavioral Tests
Behavioral tests were performed from P31 to P41. Detailed
protocol can be found in (17).$
The Elevated Plus Maze (EPM)
The test assesses anxiety-like behavior (17). Rats were placed in
the central area, head facing one of the enclosed arms. Number
of entries in the open or closed arms, time spent on each arm,
head-dipping and rearing were recorded over 5min to investigate
anxiety-like state. The ratio based on the time spent in the closed
arms and the time spent in the open spaces (open arms and center
of the apparatus) was calculated by time in open space divided by
time in closed arms (18).
The Open Field (OF)
Motor activity, exploratory drive, and anxiety state were assessed
in this test in a circular arena (100 cm diameter) divided in 21
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areas. The latency to leave the central circular area, the number
of areas crossing and rearing were recorded for 5min (17).
The Novel Object Recognition (NOR)
The novel object recognition (NOR) test was performed in the
open field arena during two consecutive days. In the first day,
each rat was confronted with two identical objects (A and A′)
placed 20 cm apart from the walls of the apparatus. The time
exploring each object was recorded for 4min. In the second day,
long-term memory was tested by exposing each animal to two
objects in the same open field apparatus: one of the objects used
in the first day, considered as the familiar object (A) and a novel
(and distinct from A or A′) object (B). Object exploration time
for each object was measured and a discriminative index (DI)
was calculated by exploration time on object B minus exploration
time on object A divided by total exploration time on both
objects (19).
The Beam Walking (BW)
The beam walking (BW) test was composed of training phase
and testing phase. In the first day, rats were trained (three
trials) to traverse a wooden beam (width 2 cm, length 100 cm,
elevated 70 cm above the floor). They were placed on one side
and encouraged to walk to reach a black box on the other side
of the beam. In the next day (24 h later) animals were exposed to
the same beam and number of hind paw slips were counted as an
index of locomotor deficits (17).
The Morris Water Maze (MWM)
The Morris water maze (MWM) was done for 6 days (5 days of
training and 1 day of test—namely Probe Trial) consecutively in a
black tank (200 diameters) filled with water (45 cm depth) at 21±
2◦C. A black platform (diameter 10 cm) was placed at 2 cm under
water level and remained hidden at the same location for the 5
training days. Rats underwent four trials with 10min inter-trial
interval per day and entered the pool facing the wall following
a randomized sequence of the four starting points (North, East,
South, and West). Latency to find the platform was measured up
to 60 s and was considered as a learning indication. If the animal
failed in finding the platform within the 60 s, it was conducted
to the platform by the experimenter and left during 10–15 s for
exploring the room clues. On the 6th day, the probe test trial day,
the platform was removed and latency to cross the platform zone
and time spent in the platform quadrant were assessed.
Statistics
For statistical analysis, a one-way ANOVA test followed by Tukey
post hoc was done for normally distributed data. A Kruskal–
Wallis test followed by a Mann–Whitney test (P < α/number
of tests) was done in case of non-normal distribution. Finally,
the mean number of PV+ cells, WFA+PVI, and the overall
8-oxo-dG labeling intensity were compared between the three
experimental groups and analyze with ANOVA test followed by
a Dunnett test. Significance level was considered when P < 0.05
after rectification of P-values by Bonferroni correction. All data
are presented as mean ± SEM except DTI and NODDI derived
FIGURE 1 | High: dam weight monitoring through gestation (G1 to G21) and
lactation until weaning (P1 to P21). Low: rat pups weight monitoring from
post-natal day 1 to 41 (P1 to P41). Results are mean ± SEM. P < 0.05 *CTL
vs. IUGR, $CTL vs. IUGR_Lf.
parameters as well as PV andWFA cells results expressed as mean
± SD.
RESULTS
Caloric Restriction Effects on Maternal and
Offspring Weights
In order to evaluate the impact of a 50% caloric restriction on
dams, weights were measured daily during both gestation and
lactation (Figure 1). Maternal body weights were significantly
decreased in IUGR and IUGR_Lf groups compared to CTL
group. The difference persisted postnatally until weaning. While
IUGR and IUGR_Lf gained only 17% of initial weight at
gestational day 21 (G21), whereas CTL dams gained 50% of initial
weight. No significant effect of Lf supplementation was perceived
on the IUGR_Lf dams compared to the IUGR ones. However,
IUGR_Lf dam body weights were no longer statistically different
from the control groups at the third week of lactation.
At P1 (Figure 1), IUGR and IUGR_Lf pups were lighter than
CTL pups. At P7 and 14, only IUGR pup weights were different
from CTL group. From P21, pups grew with no significant
difference among them.
Microstructural Integrity
To allow the assessment of cerebral microstructure, diffusivity
(Mean, MD; Axial, AD and Radial, AD), fractional anisotropy
(FA) and direction encoded color maps (DEC), intra-neurite
volume fraction (ficvf ), cerebrospinal volume fraction (fiso) and
orientation dispersion index (ODI) maps acquired at P7 and
P21 on a 9.4T scanners are presented in Figure 2. High Signal-
to-noise ratio and very good resolution were obtained leading
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FIGURE 2 | Diffusivity (Mean, MD; Axial, AD; Radial, RD), fractional anisotropy (FA) and direction encoded color (DEC) maps, intra-neurite volume fraction (ficvf ),
cerebrospinal volume fraction (fiso), and orientation dispersion index (ODI) maps at P7 and P21 for each group.
to accurate measurement of the DTI and NODDI derived
parameters (20).
Cortical Microstructure
Cortical DTI and NODDI derived parameters assessing cortical
microstructure integrity, were obtained by diffusion MR imaging
(Figure 3). IUGR and CTL derived parameters were not different
from each other at P7, but IUGR_Lf parameters were different
compared to the IUGR group: Indeed, a significant decrease
in radial (RD) and mean diffusivity (MD), and also increased
fractional anisotropy (FA) and intraneurite volume fraction
(ficvf ) were observed with Lf. At P21, caloric restriction induced
significant increase of RD, MD and fiso, this last parameter was
not restored by Lf.
In the cortex, most of the cell markers were not modified
(Figure 4). At P7, only synaptophysin expression was
significantly decreased in the IUGR group compared to
CTL, showing a potential delay in synaptogenesis (Figure 4) but
expression was similar between IUGR and IUGR_Lf cortices
(Figure 4). At P21, only MBP expression was different among
the groups (Figure 4). This marker of myelin formation and
compaction was significantly decreased in the IUGR group.
In the IUGR_Lf group, MBP expression was not statistically
different from both IUGR and CTL groups (Figure 4). Also,
Iba-1 expression was increased in IUGR pups, suggesting
an impact on microglia. However, no alteration in CD68
expression, as marker of reactive microglia, expressions in the
IUGR_Lf group were not different from the IUGR group at both
ages (Figure 4).
Key receptors, transporters and kinases taking part in the
global cerebral metabolism were quantified (Figure 5). At P7,
MCT2 cortical expression was significantly decreased in the
IUGR group (Figure 5), probably as a consequence of disrupted
energy metabolism. Also, at P7, a trend was visible with an
increased expression of leptin receptor in IUGR pups when
compared to CTL pups (P = 0.055). βCaMKII, a major kinase
in pre- and postsynaptic mechanisms and related to synaptic
plasticity, was statistically less expressed in P7 IUGR pups, and
showed a trend to be more expressed in IUGR_Lf animals
(Figure 5, P = 0.086). No statistical difference was observed in
the IUGR_Lf group (Figure 5). Protein and gene expressions
involved in growth, differentiation and survival, as well as
in apoptotic pathways were analyzed by immunoblotting and
RT-qPCR. Cortical mRNA levels of BDNF showed a trend
(P= 0.068) to be decreased (Figure 5) and the Bcl-2 mRNA level
was significantly decreased in the P7 IUGR group (Figure 5),
whereas no statistical difference with IUGR_Lf was observed
(Figure 5) compared to CTL. Fractin expression, known to
attest caspase 3 activity, was not statistically different among the
groups (Figure 5).
At P21, we assessed whether a hypocaloric induced IUGR
would induce oxidative stress in the brain of rat pups, leading
to impairment of the cortical parvalbumin (PV) expressing
neurons, known to play a critical role in cognition. A significantly
higher 8-oxo-dG [marker for DNA oxidative damage (21)] in
the cortex of hypocaloric induced IUGR pup rats compared to
control was observed (P < 0.0001, Figure 6). We have previously
established that oxidative stress during development leads to PV-
IR and WFA+ PV cell deficit (22, 23). Indeed the number of
PV-IR cell and PV-IR cell intensity in the ACC of IUGR rats
were significantly decreased compared to CTL (Figure 6, # of PV
cell: P = 0.0044, and PV-IR cell intensity: P = 0.047, not shown).
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FIGURE 3 | Histogram of diffusivities (Mean, MD; Axial, AD and Radial, RD; ×10−4 mm2.s−1), fractional anisotropy (FA), intra-neurite volume fraction (ficvf ),
cerebrospinal volume fraction (fiso), and orientation dispersion index (ODI) at P7 and P21 in the cortex. Results are mean ± SD. P < 0.05, *CTL vs. IUGR, $CTL vs.
IUGR_Lf, £IUGR vs. IUGR_Lf. *Effect of the lesion; £effect of Lf, red positive, black negative; *, £effect of the lesion restored by Lf; *,$effect of lesion but no effect of Lf;
*, £,$effect of the lesion partially restored by Lf.
FIGURE 4 | Normalized protein expression to the control group level in CTL,
IUGR, and IUGR_Lf pups at P7 (high panel) and P21 (low panel) in the cortex.
Results are mean value ± SEM. N = 5–7 pups per group (P7) and N = 9–14
pups per group (P21). P < 0.05 *CTL vs. IUGR. Raw data in
Supplementary Tables 1, 2.
However, the WFA+ PV cells, which are PV+ cells surrounded
by PNN were not strongly affected as the decrease in IUGR rats
vs. CTL remained at a trend level.
In order to assess the subsequent damages of oxidative stress
on PV-IR cells andWFA+ PV (PNNs) during early post-weaning
ages, we assessed whether Lf could prevent PV-IR and PNN
impairment in ACC of IUGR rats. Indeed, Lf supplementation
during development prevented increase of 8-oxo-dG intensity in
the ACC of IUGR_Lf rats as compared to IUGR rats (P < 0.0001,
Figure 7). The oxidative stress marker levels, 8-oxo-dG intensity,
in ACC of IUGR_Lf rats did not significantly differ from that of in
control rats. Lactoferrin also fully restored the number of PV-IR
cells in ACC of IUGR_Lf compared to IUGR alone (P = 0.001),
and compared to CTL rats (P = 0.65, NS). Interestingly, the
WFA+ PV (PV PNNs) deficit in ACC of IUGR rats was not
prevented by Lf (P = 0.23, NS).
Striatum
DTI and NODDI derived parameters were measured in the
striatum (Figure 7). IUGR striatal microstructure integrity
presented significant alterations compared to the CTL group.
Increase in AD and RD at P7 and P21, as well as decrease in ficvf
and increase in fiso at P7 depicted microstructural changes. DTI
and NODDI parameter changes were reverted in P7 IUGR_Lf
pups and partially at P21.
Structural proteins used as cell markers in the striatum were
not differentially expressed between the groups. However, NG2
expression was increased at P7 in IUGR_Lf striatum compared
to the IUGR group (Figure 8). In striatum, at P7, the apoptotic
pathway was potentially affected in IUGR pups with the anti-
apoptotic Bcl-2 mRNA expression statistically downregulated
and data showed a tendency (P = 0.053) to be reversed in
IUGR_Lf when compared to IUGR pups. At P21 (Figure 8,
lower panel), alteration in synaptic plasticity in the IUGR group
was depicted by a statistical decrease in βCaMKII expression
compared to the CTL group. This altered expression was reverted
in the IUGR_Lf group. Fractin quantification was not statistically
different among the groups. Growth factor IGF2 was found to be
statistically increased in IUGR at P21 with no statistical difference
in IUGR_Lf.
External Capsule
DTI and NODDI derived parameters in external capsule white
matter tract are shown in Figure 9. At P7, RD was significantly
increased in IUGR pups and reversed, along with a decrease in
AD and MD, in IUGR_Lf when compared to IUGR. In the P7
IUGR_Lf group, ficvf and fiso were also significantly different from
the IUGR group and there was no statistical difference between
IUGR_Lf and CTL pups.
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FIGURE 5 | Cortical protein (normalized to the control group level) involved in global brain mechanisms such as metabolism, growth and apoptosis for CTL, IUGR,
and IUGR_Lf pups at P7. Quantification was done either after immunoblotting or RT-qPCR. Selection of metabolic transporter and receptor expressions (GLT1, MCT2,
DMT1, CaMKIIβ, and Leptin R) and proteic feature of apoptosis (Fractin). Expression of pro- and anti-apoptotic mRNA (Bax and BCL2) and growth factor BDNF
mRNA expression (BDNF). Results are mean values ± SEM of N = 6–7 pups per group. P < 0.05 *CTL vs. IUGR. Raw data in Supplementary Table 3.
FIGURE 6 | Interneurons assessment in the cortex at P21. (A) Micrographs
showing labeling for 8-oxo-dG (labels mitochondrial DNA oxidation), PV, and
WFA (labels PNN) in ACC of CTL, IUGR, and IUGR_Lf. (B) Lactoferrin prevents
increase in 8-oxo-dG labeling. (C) Quantification reveals that Lactoferrin
restores PV immunoreactive cell deficits in hypocaloric induced IUGR rats. (D)
There is a tendency for lactoferrin to prevent decrease of PNN (WFA + PV) in
hypocaloric induced IUGR rats. Bars in all graphs represent SD. For each
group n = 4 (for each animal 3–4 brain sections). *CTL vs. IUGR, £IUGR vs.
IUGR_Lf, number of * or £: 3 P < 0.001; 2 P < 0.01; Scale bar: 50µm.
Behavioral Tests
Cognitive and motor functions were assessed by a battery of
behavioral tests performed between P31 to P41. These tests target
behavioral aspects that could be impaired in IUGR children,
such as motor activity, attention, memory and anxiety. Rats were
frequently observed and monitored; pups from IUGR groups
did not exhibit any abnormalities in motion, activity or basic
behavior compared to the controls.
Elevated Plus Maze (EPM)
The elevated plus maze assesses the motor activity as well as the
anxiety level. The global activity between the groups was not
different and showed the three groups staying more in the closed
arms than in the open ones (Figure 10). Ratio of time spent in the
open to time spent in the closed arms did not show any difference
among groups.
Open Field Test (OFT)
This test assesses the exploratory drive, as well as the global
activity. Rats usually avoid open spaces and rather prefer
exploring the area close to the wall (thigmotaxis). This trend
was visible within the three groups (Figure 10). However, no
differences were observed.
Beam Walking Test (BWT)
Locomotor activity and coordination were assessed by BWT.
The number of paw slips was converted into digits and counted
as number of mistakes. No statistical differences were found
between the groups (Figure 10).
Novel Object Recognition (NOR)
The NOR test was used to assess long-term memory. Rats were
confronted to two objects in the 2 sessions of testing: two familiar
objects (objects A and A′) and a new one (object B). The data did
not detect preferences for the new objects nor differences within
groups (Figure 10).
Morris Water Maze (MWM)
In the day of the test (Probe Trial) when the platform was
removed, the time to find the platform zone was measured
(Figure 10). CTL pups performed significantly better, crossing
the platform region faster than IUGR and IUGR_Lf groups.
The ability to learn did not vary between the groups during the
training phase.
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FIGURE 7 | Histogram of diffusivities (Mean, MD; Axial, AD and Radial, RD; ×10−4 mm2.s−1), fractional anisotropy (FA), intra-neurite volume fraction (ficvf ),
cerebrospinal volume fraction (fiso), and orientation dispersion index (ODI) at P7 and P21 in the striatum. P < 0.05, *CTL vs. IUGR, $CTL vs. IUGR_Lf, £IUGR vs.
IUGR_Lf. *Effect of the lesion; £effect of Lf, red positive, black negative; *, £effect of the lesion restored by Lf; *,$effect of lesion but no effect of Lf; *, £,$effect of the
lesion partially restored by Lf.
FIGURE 8 | Striatal protein (normalized to the control group level) for CTL,
IUGR, and IUGR_Lf pups at P7 (high panel) and P21 (low panel). Structural
protein expression at P7 (DCX, NeuN, Synapto., NG2, GFAP, CD68, and Iba1).
Expression of striatal pro- and anti-apoptotic mRNA at P7 (Bax and BCL2).
Selection of metabolic transporter and receptor expressions in the striatum at
P21 (MCT2, NMDar2a, DMT1, CaMKIIβ, and Leptin R). Growth factor molecule
and receptor mRNA expression in the striatum at P21 (TrKB and IGF2).
Results are mean values ± SEM of N = 3 to 14 pups per group. P < 0.05
*CTL vs. IUGR, £IUGR vs. IUGR_Lf. Raw data in Supplementary Tables 4, 5.
DISCUSSION
In the present study, we explored the potential neuroprotective
action of maternal bovine lactoferrin (Lf) supplementation on a
50% CR-induced IUGR model. As IUGR is thought to induce
a delay in neurodevelopment, we addressed special focus on
brain microstructural integrity, cell markers as well as metabolic
proteins and gene expressions, which are important in cerebral
development and injury. Further investigations were pursued
for behavioral deficits. Analyses were performed at P7, P21 and
from P31 to P41. P7 corresponds to the near term equivalent
age for humans. P21 corresponds to the peak of myelination and
cortical maturation providing already good information about
the consequences of IUGR and potential Lf neuroprotection.
Behavioral tests were performed at a time period where
myelination is nearly completed (P31 to 41, preadolescent human
equivalent) and as such potential mental disabilities can be
observed in children at this time point. Indeed, these tests target
behavioral aspects that could be impaired in IUGR children, such
as motor activity, attention, memory and anxiety.
IUGR Model
Despite any effect of Lf supplementation on the weight of the
dams, evidences validated our CR-induced IUGR model as it
reduced maternal weight gain during gestation and had long-
lasting effect during lactation period. While control dams gained
50% of their initial body weight by the end of gestation, restricted
animals gained only 17%. This reduced maternal weight gain
was also observed in a previous study using a stress induced
model (maternal dexamethasone infusion) during the third week
of gestation (12) and by others (24). Low birth weight in IUGR
newborns is considered as a major indicator of prenatal insults.
Pups were weighted at P1, and as both restricted diets were
isocaloric, it was not expected that nutritional supplementation
with Lf would improve low body weight in P1 IUGR pups
indicating that offspring birthweight is highly dependent on the
maternal food caloric intake during gestation. However, while
IUGR pups receiving Lf through lactation caught up control body
weight at P7, IUGR catch-up was only observed at P21. This
gives rise to a potentially improved early metabolism in IUGR
pups receiving Lf. In a placental insufficiency model, pups with
moderate IUGR had a catch-up growth at P7, whereas catch-up
growth in severe IUGR pups was not reported (25).
Cortical Impairment and Effects of
Lactoferrin
We reported a decrease in cortical synaptophysin expression
at P7 in whole cortical homogenate tissue, resulting from
caloric restriction. As IUGR neurodevelopment is thought
to be delayed due to reduced nutrients during a critical
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FIGURE 9 | Histogram of diffusivities (Mean, MD; Axial, AD and Radial, RD; ×10−4 mm2.s−1), fractional anisotropy (FA), intra-neurite volume fraction (ficvf ),
cerebrospinal volume fraction (fiso), and orientation dispersion index (ODI) at P7 and P21 in the external capsule. P < 0.05, *CTL vs. IUGR, $CTL vs. IUGR_Lf, £IUGR
vs. IUGR_Lf. *Effect of the lesion; £effect of Lf, red positive, black negative; *, £effect of the lesion restored by Lf; *,$effect of lesion but no effect of Lf; *, £,$: effect of
the lesion partially restored by Lf.
FIGURE 10 | Behavioral test results for CTL, IUGR, and IUGR_Lf pups. Elevated plus maze: ratio measuring the time spent in open space divided by the time spent in
closed arm in the elevated plus maze. The center of the apparatus was considered as open space. Open field test: exploratory drive analysis by number of lines
crossed in the central and peripherical zone, and in total in the open filed test. Novel object recognition: preferences between familiar and new object in novel object
recognition. First object explored (familiar object = 0 and new object = 1) and Discrimination index showing preference for the new object. Beam walking test: number
of paw slips during the beam walking test. Morris water maze: time to find the platform zone in the Morris water maze with learning curve displaying the time to find
the platform through the five-day training (Day values are the mean of four trials) and time to find the platform zone the day of the test. All results are mean values ±
SEM, N = 16–26 pups per group. P < 0.05 *CTL vs. IUGR, £IUGR vs. IUGR_Lf.
phase of cerebral development (26–28), the present result
suggest that IUGR leads to transient delay in synaptogenesis
in the cortex in P7 restricted rats. Similarly in sheep (29),
impaired fetal environment was induced by an intra-amniotic
lipopolysaccharide pro-inflammatory environment and cerebral
synaptophysin expression was reported to be decreased in motor,
somatosensory and entorhinal cortices causing reduction in
density of presynaptical boutons.
A decrease in beta Ca2+/calmodulin-dependent protein
kinase II (βCaMKII) expression in the cortex further supports
this interpretation. βCaMKII is activated by calcium and is an
important kinase targeting substrate responsible for long-term
potentiation (30). In vitro overexpression induced an increase
in the number of neurite extensions and in formation of new
synapses (31). Therefore, it is related to morphology and quantity
of synapses (32) by modifying the cytoskeletal structure. Along
with our previous results on synaptophysin expression, decrease
in βCaMKII emphasizes a potentially altered number/size of
synapses and supports a transient delay in synaptic formation and
possibly function.
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Myelin basic protein (MBP) is one of the main components
of myelin sheath structure and primordial for its formation and
compaction and for axonal. In the current study, MBP expression
was reduced in the cortex in IUGR pups at P21. Uterine
artery ligation IUGR induced models have been widely used to
approach white matter damage linked to perinatal impairments
such as prematurity or fetal growth restriction observing a
similar reduction in MBP density in the corpus callosum and the
cingulum, sign of myelination defect (24).
Moreover, cortical expression of Iba-1, a microglial protein,
was increased at P21. As it is expressed in both quiescent
and amoeboid form and even though it is upregulated by
activation (33), we quantified CD68 expression in order to
identify properly activated microglial. However, CD68 analysis
failed to identify microglial activation induced by IUGR. In a
placental insufficiency rat model, inflammatory microgliosis was
reported to impair white matter development (24). Indeed, using
another marker (OX42) for immunohistochemistry, a higher
density of microglia was observed in IUGR rats. Taken together,
myelin integrity alteration concomitant with increased microglia
density are in accordance with others work (14). Even though,
our current results showed comparatively less microstructural
alterations, it may further demonstrate the neuroinflammatory
basis for cerebral impaired development in IUGR condition.
Despite an absence of significant differences, a tendency
in the up-regulation of βCaMKII, synaptogenesis and MBP
levels was observed in the Lf supplemented group providing
evidence for a beneficial effect on cortical development. Indeed,
DTI and NODDI derived parameters demonstrated a potential
conservation of the microstructure in the cortex at P7 in
IUGR_Lf rats compared to IUGR even though at P21 remaining
impairments detected by diffusion MRI appeared moderates in
the IUGR group. Altogether these results suggest that Lactoferrin
reduces the delayed and impaired cortical development following
caloric restriction.
We have demonstrated that redox dysregulation and oxidative
stress (genetic or environmental origin) during development, in
several animals models relevant to schizophrenia and autism,
at microcircuit levels, leads to excitatory-inhibitory imbalance
through impairment of the PV inhibitory network and their
PNN (23, 34, 35). Similar redox dysregulation processes during
development, at macrocircuit levels, could underlie impaired
oligodendrocytes and delayed cortical myelination (34, 36).
Parvalbumin immunoreactive (PV-IR) cell, oligodendrocyte and
myelination impairment have been reported in schizophrenia
(37). Abnormal control of redox system could therefore affect
neuronal synchronization important for cognitive processing,
and also disturb myelination leading to subsequent white matter
injuries. N-acetyl-cysteine (NAC) is an antioxidant demonstrated
to prevent oxidative stress during development and as such,
to protect PVI and PNN. Clinically, several positive effects
of NAC have been observed including an improvement of
negative symptoms, a decrease of antipsychotics side effects,
and an improvement of mismatch negativity and local neural
synchronization in chronic schizophrenic psychosis. Recently,
Conus et al. (38) observed on early psychosis patients that NAC
add-on therapy for 6 months led to significant improvements
in neuro-cognition and a reduced positive symptoms in patients
presenting high oxidative status.
In the present study, lactoferrin prevents oxidative stress thus
restoring PV-IR cell deficits in ACC of hypocaloric induced
IUGR rat pups. Lactoferrin could have prevented oxidative stress
and restored PV-IR impairment through anti-inflammatory and
antioxidant properties in the same way as NAC does, even
without improving MBP expression (myelination). Although
beyond the scope of the present study, it may prove vital for the
future studies to look into additional functional consequences
of hypocaloric induced IUGR, such as mismatch negativity
(sensory gating), and fast spiking neuronal synchronization
(important for cognitive and social processing), and the
effect of lactoferrin supplementation. This would certainly
shed additional light on the contribution of a developmental
undernutrition in psychiatric disease such as schizophrenia and
potential prevention.
Impaired Microstructure in Striatum and
Restoration With Lf
MR Imaging of the striatum of IUGR pups showed promising
improvement of the neurodevelopment with Lf. The striatum is
a vulnerable gray matter area in developing brain (11), which
was proposed to be especially affected in case of periventricular
leukomalacia and may be related to mild motor deficits (39) but
also potentially to psychiatric disorders such as schizophrenia
(40). In the present study, at P7, microstructural organization was
altered or delayed, as depicted by reduction of the neurite density
(ficvf ) and dispersion of the fibers (ODI) were reduced whereas
isotropic volume fraction (fiso) was increased. No changes in cell
markers used in the current study were identified, suggesting
alterations of arborization/maturation rather than in neuronal
or glial reduced populations. No difference in MBP expression
was observed, however, the low level of MBP immunostaining
of brain sections at early time-point did not allow a structural
assessment in the axonal fascicles. Nonetheless, these parameters
were normalized with Lf, promoting a better integrity of the
striatum in the first week after birth. Similar neuroprotective
effect of Lf was observed at longer term (P21) in the striatum
following lipopolysaccharide injection in the rat pup (11). MCT
2 expression in the striatum was decreased as observed in
the cortex. Similar to the cortex, striatal mRNA expression
of Bcl-2 was also downregulated and normalized with the Lf
supplementation. As Bax expression was not affected by IUGR,
reduction in anti-apoptotic protein presumed an increased
apoptotic rate in IUGR condition (Bax/Bcl-2) (41). However, no
increase in fractin expression was visible. Interestingly, βCaMKII
protein expression was reduced in IUGR and restored with Lf at
P21. Lactoferrin administration also improved striatal expression
of βCaMKII. DTI/NODDI and βCaMKII findings suggest
reduced arborization as consequence of IUGR reversed by Lf.
External Capsule, IUGR Impact on White
Matter Tracts, and Repair With Lf
In external capsule, increased water diffusivity was observed
perpendicularly to the main diffusion direction at P7. This
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abnormal RD was associated with increased fiso and reduced
neurite density emphasizing clearly for a defective myelin
organization. RD in the external capsule and corpus callosum
were also increased in P21 moderate—but not in mild—IUGR
pups after placental insufficiency (42). As it was correlated with
poor oligodendrocyte density and an abnormal percentage of
unmyelinated axons, RD modification was suggested to result
readily from this myelin injury. All these studies related impaired
neurodevelopment with alteration in the external capsule around
3 weeks of age. By this time, oligodendrocyte and astrocyte
proliferations and maturations stage is likely to be finished.
However, in our case, the microstructural alterations of external
capsule were observed in P7 pups transiently as almost no
difference was measured at P21. Positive effect of Lf at 7 days
point was obvious. Our model further argues for a potential delay
in myelination process rather than a long-lasting injury.
Neuroprotection with Lf was assessed in the inflammatory
(11) and hypoxic-ischemic (10) models, as well as in the present
CR model. While partial normalization was observed in the case
of brain inflammation, diffusivities were fully normalized in the
hypoxic-ischemic injured brain, such as the RD in the present
study. Supplementation with Lf appeared to improve impaired
white matter formation.
Limitation of IUGR Impact and
Neuroprotection by Lf
The present study further illustrates the complexity of the
IUGR condition, which depends on the timing, the severity, the
heterogeneity of risk factors and pathways potentially impaired
that are mimicked by various animal models. Maternal stress,
placental insufficiency and undernutrition mimicking-models
were all reported to interfere with fetal trajectory growth but
altered pathways are very likely to differ depending on the risk
factor (43). Our present model, moderate undernutrition, using
a 50% caloric restriction during gestation, is likely to induce a
mild and transient impairment to the neurodevelopment despite
the IUGR phenotype. We believe that part of the non-significant
changes seen in the model and the partial Lf neuroprotection
are due to the mild IUGR model used. It is important to notice
that mild IUGR has been also reported in humans with moderate
but depicted developmental impairments (44). It is important to
notice that this model mimics one type of environmental risk
which is necessary but not sufficient by itself alone to reproduce
fully the clinical phenotypes. One may need the combination
with genetic risks as well. As such, the mildness of the model
is evident and may be responsible for absence of behavioral
impairments. Furthermore, behavior evaluation was made at
childhood age before adulthood where psychiatric symptoms
generally occur following IUGR including social problems, poor
cognitive performances, anxiety, and schizophrenia (45). Notice
that, due to the variability of the caloric restriction model and
according to the high number of different techniques used in this
study, number of pups in each group was not large enough to
assess possible gender differences but it is point to consider in
further experiments.
CONCLUSION
In this study, we show that IUGR induced by moderate
undernutrition demonstrated mild cerebral impairments.
Cortical synaptogenesis and myelination were potentially
delayed. Striatal microstructure showed alterations. The
white matter integrity assessed in the external capsule
presented abnormal development. Lf supplementation
showed beneficial restoration in the cortex, in the striatum
microstructure and in the white matter organization of the
external capsule. Further Lf showed reduced oxidative stress
in ACA interneurons. This model does not fully represent the
clinical situation as IUGR newborns often cumulate adverse
conditions in addition to IUGR, such as hypoxia-ischemia or
infection/inflammation. Nevertheless, oral Lf supplementation
showed partial neuroprotection in this CR IUGR model.
This is also neuroprotective against hypoxia-ischemia and
inflammation in the developing brain, and thus represents a very
promising tool to reduce developmental diseases in IUGR and
preterm infants.
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